Maxwellia on course to launch self-care alternatives following £3.2m funding round

A Cheshire business that aims to transform the UK’s self-care market has secured a £3.2m investment in a funding round led by Manchester-based Praetura Ventures. Maxwellia, which is based at Alderley Park, aims to give people easier a...

Deals agreed as Infex's resistance bypass drug program heads for clinic

Alderley Park, Cheshire Infex Therapeutics has appointed Pharmaron to help progress its MET-X program which targets urinary tract infections caused by WHO critical-priority resistant Gram-negative bacteria. Pharmaron will manufacture the pat...

Panthera Biopartners appoints corporate financier Christopher Steed as a non-executive director to continue UK and overseas expansion

Independent clinical trial site management organisation (SMO), Panthera Biopartners, has appointed M&A and fundraisings adviser Chris Steed as a non-executive director. Chris has over 25 years’ experience as a corporate financier, w...

Infex focuses on pandemic preparedness with Covid patent

Infex Therapeutics has filed for a UK patent for a novel therapy designed to tackle all coronavirus strains. The COV-X program targets a protein which is essential for viral replication across a broad spectrum of related coronaviruses, including...

Healum closes investment round to develop UKRI funded AI powered patient management system for people with long term conditions

MANCHESTER, UK, 25th March 2021 - Healum, a leading digital health company, known for developing a ground-breaking AI powered patient management system to improve health outcomes and quality of life for people with long term conditions, has raised...

From our portfolio



viewview our portfolio

Our Team

Nick Wright


view complete team

Contact us

Alderley Park
Alderley Edge
SK10 4TG

Tel: 01625 344300